NeoGenomics, Inc.
NEONASDAQHealthcareDiagnostics & Research
As of Oct 22, 2026 close
- Market cap
- $428.86M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $7.07$20.15
- Volume (live)
- -
- Avg. volume (3M)
- 2.26M
NeoGenomics (NEO) Stock Price & Financial Analysis
NeoGenomics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $16.13 - $17.17 |
|---|---|
| 52-Week High | $20.15 |
| 52-Week Low | $7.07 |
| Open | $16.89 |
| Volume (last close) | 2.46M |
| Average Volume (3M) | 2.26M |
| Revenue (TTM) | 766.29M |
|---|---|
| Net Income (TTM) | -51.88M |
| Free Cash Flow (TTM) | -7.36M |
| EPS (TTM) | −$0.67 |
| Profit Margin | -6.77% |
| Operating Margin | -8.63% |
| Return on Equity (ROE) | -6.60% |
| Debt to Equity | 0.48 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Dec 17, 2020 |
| Market Cap | 428.86M |
|---|---|
| Shares Outstanding | 26.17M |
| Price to Sales (P/S) | 0.56 |
| Price to Book (P/B) | 0.55 |
| EV/EBITDA | 27.53 |
| 50-Day MA | $17.55 |
|---|---|
| 200-Day MA | $12.61 |
| 1-Year Change | +56.84% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
NeoGenomics at a Glance
As of the Oct 22, 2026 close, NeoGenomics (NEO) has a market capitalization of $428.86M. The stock trades at 0.6× sales. Over the trailing twelve months it lost $51.88M on revenue of $766.29M and burned $7.36M of free cash flow. Revenue grew 11.2% year over year.
As of its latest reported balance sheet, it holds $145.54M in cash and securities against $379.67M of debt, a net debt position of $234.13M.
NeoGenomics does not currently pay a dividend.
The share price is up 56.8% over the past year. At $16.39 (the Oct 22, 2026 close) it sits within its 52-week range of $7.07 to $20.15, above its 200-day moving average of $12.61.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $21.50, 31.2% above the Oct 22, 2026 close.
Frequently Asked Questions About NeoGenomics
What is the current stock price for NEO?
As of the Oct 22, 2026 close, NEO stock trades at $16.39. The 52-week range is $7.07–$20.15, with a day range of $16.13–$17.17.
What is the P/E ratio for NEO?
The P/E ratio (Price-to-Earnings) for NEO is shown in the Key Statistics section. This valuation metric helps compare NeoGenomics, Inc. to industry peers.
Does NEO pay dividends?
NeoGenomics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NEO?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for NEO is Buy. The average 12-month price target is $21.50, a 31.2% upside from the Oct 22, 2026 close of $16.39.
What is the market cap of NEO?
As of the Oct 22, 2026 close, NeoGenomics's market capitalization is $428.9M, classifying it as a small-cap company. NeoGenomics operates in the Healthcare sector within the Diagnostics & Research industry.